Health ProductsNotice to Hospitals

Important Safety Information on the Interactions between Active Implantable Medical Devices and Systems and other Medical Devices - Revision - Notice to Hospitals

· Published by Health Canada · Official notice

Details

Alert type: Notice to Hospitals
Category: Medical Device
Audience: Hospitals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

Notice about Health Canada advisories

 
[Text of letter begins]

Notice to Hospitals - Health Canada Issued Important Safety Information on Active Implantable Medical Devices and Systems

An updated Notice to Hospitals has been posted on Health Canada web site on December 20, 2005.

October 31, 2005

To: Hospital Chief of Medical Staff

Please distribute to the relevant Departments of Physiotherapy, Occupational Therapy, Radiology, Rehabilitative Medicine, Surgery, Neurosurgery, Orthopedic Surgery, Biomedical Engineering, Emergency Medicine, Pediatrics, Geriatrics, Internal Medicine, Nursing, Dentistry, Intensive Care and other involved professional staff and post this NOTICE in your institution.

Subject: Interactions between active implantable medical devices and systems and other medical devices

This is a revision of the information in the Health Canada Notice to Hospitals dated October 5, 2005.

Patients with active implantable medical devices and systems (AIMDS) are at risk of injury from interactions between the AIMDS and other medical devices used for diagnostic or therapeutic purposes. Such interactions could damage some AIMDS resulting in loss of therapy from these units, and could cause tissue damage resulting in severe injury or death. Patients may be at risk even if the leads are not connected to an implantable device or even if the device is off.

On April 2, 2003, Heath Canada issued a Notice to Hospitals entitled "Important safety information regarding DIATHERMY THERAPY in patients with implanted leads and implanted systems with leads".Footnote 1 It warned about the risks of tissue overheating, serious injury and death in this group of patients when subject to shortwave (radiofrequency) or microwave diathermy therapy. Since then, Health Canada has become aware of further international reports of serious injury resulting from interactions between AIMDS and other medical devices.Footnote 2

In 2003, the French Health Products Safety Agency, Agence française de sécurité sanitaire des produits de santé (AFSSAPS), assembled a working group to analyse the recommendations of AIMDS manufacturers and make recommendations to health care professionals who perform certain diagnostic and therapeutic procedures on patients with AIMDS. The recommendations of the group were released by AFSSAPS in February 2005.Footnote 3 Health Canada has reviewed these recommendations and is presenting them in an adapted form as follows:

The recommendations of the group were released by AFSSAPS in February 2005.
  Implanted Cardiac Pacemaker Implanted Cardiac Defibrillator Implanted Neurostimulator

Table 1 footnotes

Table 1 footnote 1

For the medical procedures listed above where precautions are suggested, a risk-benefit analysis of the proposed medical procedure, including careful consideration of the alternatives, should be undertaken. Consultation with the referring physician and implanting/monitoring physician should be considered and the labelling of relevant devices (including warnings/precautions) should be reviewed. The exact risks to patients and precautions to be taken in each circumstance are outlined in detail in the AFSSAPS document and should be reviewed.Footnote 3 In general, if a decision is taken to go ahead with a medical procedure that requires precaution, Health Canada recommends the following:

  • if possible, deactivate the AIMDS
  • use the lowest device strength compatible with an acceptable diagnostic or therapeutic outcome and keep the path of device output as far from the AIMDS as possible
  • monitor the patient closely during the medical procedure
  • stop the procedure immediately in the case of an adverse incident
  • verify the continued proper function of the AIMDS during and after the medical procedure

Return to table 1 footnote * referrer

Shortwave and Microwave Diathermy Absolute contraindication Absolute contraindication Absolute contraindication
Ultrasound Diathermy Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Absolute contraindication
Electromagnetic Stimulation Device Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Absolute contraindication
MRI Absolute contraindication Absolute contraindication Absolute contraindication
Electrosurgery Device Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote *
External Defibrillator Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote *
Radiotherapy Device Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote *
Lithotripsy or Ultrasound Therapy Device Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote * Take PrecautionTable 1 footnote *
Fluoroscopy or other X-ray Devices No contraindication No contraindication No contraindication
Echography No contraindication No contraindication No contraindication

The risk of interactions between AIMDS and other medical devices used for diagnostic or therapeutic purposes depends on many parameters. Due to the diversity and complexity of the devices in question, Health Canada wishes to pass along these general guidelines but cannot give all-encompassing recommendations that cover all possible clinical scenarios. Health Canada continues to monitor this evolving safety issue and will release more information as it becomes available.

Health Canada depends on health care professionals to report adverse incidents related to medical devices. Any serious and/or unexpected adverse incident related to medical devices should be reported to Health Canada at the following address:

Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Tel: The Inspectorate Hotline 1-800-267-9675

For other inquiries, please refer to contact information:
Marketed Health Products Directorate (MHPD)
Email: MHPD_DPSC@hc-sc.gc.ca
Tel: (613) 954-6522
Fax: (613) 952-7738

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.

[Text of letter ends]
 

Footnotes

Footnote 1

Important safety information regarding DIATHERMY THERAPY in patients with implanted leads and implanted systems with leads.
Notice To Hospitals. Health Products and Food Branch, Health Canada. April 2, 2003.

Return to footnote 1 referrer

Footnote 2

FDA Public Health Notification: MRI-Caused Injuries in Patients with Implanted Neurological Stimulators.
Center for Devices and Radiological Health, Food and Drug Administration. May 10, 2005.

Return to footnote 2 referrer

Footnote 3

Interactions entre dispositifs médicaux implantables actifs et dispositifs médicaux.
Agence française de sécurité sanitaire des produits de santé (AFSSAPS). February 2005.

Return to footnote 3 referrer

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime